Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS)
CNY 23.79
(-0.08%)
CNY 23.79
(-0.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 860.93 Million | 654.73 Million | 509.69 Million | 565.97 Million | 542.51 Million | 484.96 Million |
| Cost of Revenue | 95.15 Million | 76.16 Million | 62.11 Million | 62.86 Million | 63.88 Million | 64.16 Million |
| Gross Profit | 765.77 Million | 578.56 Million | 447.57 Million | 503.1 Million | 478.63 Million | 420.79 Million |
| Operating Expenses | 516.66 Million | 418.75 Million | 337.24 Million | 368.84 Million | 348.27 Million | 309.29 Million |
| Selling, General and Administrative Expenses | 417.94 Million | 325.39 Million | 270.51 Million | 298.43 Million | 283.92 Million | 256.71 Million |
| Research and Development Expenses | 55.77 Million | 55.18 Million | 29.28 Million | 33.54 Million | 31.15 Million | 19.59 Million |
| Other Expenses | -2.02 Million | 38.17 Million | 37.44 Million | 36.86 Million | 33.19 Million | -976.47 Thousand |
| Cost and Expenses | 611.81 Million | 494.92 Million | 399.36 Million | 431.71 Million | 412.16 Million | 373.46 Million |
| Operating Income | 249.11 Million | 176.4 Million | 133.63 Million | 150.55 Million | 130.05 Million | 114.21 Million |
| Interest Expense | 243.44 Thousand | 376.23 Thousand | 105.61 Thousand | 114.84 Thousand | 126.44 Thousand | 100.62 Thousand |
| Income Tax Expense | 28.71 Million | 20.27 Million | 18.21 Million | 18.67 Million | 17 Million | 16.32 Million |
| Earnings before Tax | 247.47 Million | 174.53 Million | 132.56 Million | 148.52 Million | 129.78 Million | 113.24 Million |
| Net Income | 219.08 Million | 154.66 Million | 114.9 Million | 129.71 Million | 112.91 Million | 96.61 Million |
| Earnings Per Share Basic | 1.17 | 0.83 | 0.61 | 0.69 | 0.60 | 0.69 |
| Earnings Per Share Diluted | 1.17 | 0.83 | 0.61 | 0.69 | 0.60 | 0.69 |
| Weighted Average Shares Outstanding | 187.25 Million | 186.94 Million | 186.94 Million | 186.94 Million | 186.94 Million | 140.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 187.25 Million | 186.94 Million | 186.94 Million | 186.94 Million | 186.94 Million | 140.01 Million |
| Gross Margin | 0.89 | 0.88 | 0.88 | 0.89 | 0.88 | 0.87 |
| EBIT Margin | 0.31 | 0.29 | 0.24 | 0.27 | 0.27 | 0.26 |
| Profit Margin | 0.25 | 0.24 | 0.23 | 0.23 | 0.21 | 0.20 |
| EBITDA | 265.55 Million | 164.59 Million | 119.29 Million | 150.64 Million | 143 Million | 117.77 Million |
| Earnings Before Tax Margin | 0.29 | 0.27 | 0.26 | 0.27 | 0.24 | 0.24 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 209.54 Million | 235.94 Million | 191.36 Million | 243.95 Million | 860.93 Million | 198.16 Million |
| Cost of Revenue | 22.58 Million | 25.43 Million | 20.43 Million | 26.56 Million | 95.15 Million | 22.13 Million |
| Gross Profit | 186.95 Million | 210.5 Million | 170.93 Million | 217.39 Million | 765.77 Million | 176.02 Million |
| Operating Expenses | 126.79 Million | 133.33 Million | 110.55 Million | 171.93 Million | 611.79 Million | 110.39 Million |
| Selling, General and Administrative Expenses | 200.29 Million | 125.85 Million | 100.86 Million | 95.13 Million | - | 114.71 Million |
| Research and Development Expenses | 13.76 Million | 7.47 Million | 9.69 Million | 13.67 Million | - | 13.5 Million |
| Other Expenses | -87.27 Million | -323.62 Thousand | -144.52 Thousand | -171.93 Million | -611.79 Million | -134.39 Thousand |
| Cost and Expenses | 149.37 Million | 158.76 Million | 130.98 Million | 171.93 Million | 611.79 Million | 132.53 Million |
| Operating Income | 61.02 Million | 77.17 Million | 60.37 Million | 72.01 Million | 249.13 Million | 69.08 Million |
| Interest Expense | 6219.89 | 22.89 Thousand | 56.76 Thousand | 40.09 Thousand | 105.53 Thousand | 1383.37 |
| Income Tax Expense | 8.44 Million | 10.52 Million | 7.06 Million | 6.83 Million | 28.71 Million | 10.22 Million |
| Earnings before Tax | 60.91 Million | 80.92 Million | 60.89 Million | 70.83 Million | 247.5 Million | 68.94 Million |
| Net Income | 52.55 Million | 69.49 Million | 52.51 Million | 64.01 Million | 219.08 Million | 58.8 Million |
| Earnings Per Share Basic | 0.26 | 0.35 | 0.28 | 0.33 | - | 0.31 |
| Earnings Per Share Diluted | 0.26 | 0.35 | 0.28 | 0.32 | - | 0.31 |
| Weighted Average Shares Outstanding | 199.43 Million | 196.53 Million | 189.08 Million | 190.38 Million | 187.25 Million | 189.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 199.43 Million | 196.53 Million | 189.08 Million | 190.38 Million | 187.25 Million | 189.08 Million |
| Gross Margin | 0.89 | 0.89 | 0.89 | 0.89 | 0.89 | 0.89 |
| EBIT Margin | 0.29 | 0.34 | 0.31 | 0.30 | - | 0.34 |
| Profit Margin | 0.25 | 0.29 | 0.27 | 0.26 | 0.25 | 0.30 |
| EBITDA | 60.92 Million | 80.1 Million | 58.71 Million | 73.8 Million | - | 67.55 Million |
| Earnings Before Tax Margin | 0.29 | 0.33 | 0.32 | 0.30 | 0.29 | 0.35 |
0QM4
5194
SRN
7277
DRX
3277